Unique ID issued by UMIN | UMIN000042378 |
---|---|
Receipt number | R000048324 |
Scientific Title | Prospective randomized trial of antibiotic prophylaxis in renal biopsy |
Date of disclosure of the study information | 2020/11/07 |
Last modified on | 2022/11/27 15:32:10 |
Prospective randomized trial of antibiotic prophylaxis in renal biopsy
Prospective randomized trial of antibiotic prophylaxis in renal biopsy
Prospective randomized trial of antibiotic prophylaxis in renal biopsy
Prospective randomized trial of antibiotic prophylaxis in renal biopsy
Japan |
kidney disease
Nephrology |
Others
NO
verifying whether the administration of antibiotic prophylaxis can be discontinued in renal biopsy
Bio-equivalence
the number of patients with positive urine cultures in 3 or 4 days after renal biopsy (more than 10 to the 5th power colony forming unit/ml) , or when the patient is diagnosed with pyelonephritis within two or three days after renal biopsy
the number of patients who had a diagnosis of pyelonephritis within 30 days after renal biopsy
the number of patients that who had a diagnosis of puncture site infection within 30 days after renal biopsy
the number of patients who had a diagnosis of the infection except pyelonephritis and puncture site infection within 30 days after renal biopsy
the number of patients who caused the side effect of antibiotic prophylaxis
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Prevention
Medicine |
administration of antibiotic prophylaxis
not administration of antibiotic prophylaxis
15 | years-old | <= |
Not applicable |
Male and Female
Patients who undergo percutaneous renal biopsy
Patients who present with a white blood cell count of >10/high-power field (HPF) on two occasions during the most recent urinalysis (including once within 3 days of the procedure)
patients with allergy to cefazolin
patients who received antibiotics administration within seven days before renal biopsy
patients who were inserted urethral catheters in the day before from 7 days before renal biopsy
patients with human immunodeficiency virus infection
patients with pregnancy
364
1st name | Kensei |
Middle name | |
Last name | Yahata |
Osaka Red Cross Hospital
Department of Nephrology
543-8555
5-30, Fudegasaki-cho, Tennoji-ku, Osaka
06-6774-5111
kenseiyahata@osaka-med.jrc.or.jp
1st name | Kensei |
Middle name | |
Last name | Yahata |
Osaka Red Cross Hospital
Department of Nephrology
543-8555
5-30, Fudegasaki-cho, Tennoji-ku, Osaka
06-6774-5111
kenseiyahata@osaka-med.jrc.or.jp
Osaka Red Cross Hospital
Self funding
Self funding
Kyoto University Hospital
Kitano Hospital
National Hospital Organization Kyoto Medical Center
Kyoto Min-Iren Chuo Hospital
Kobe City Medical Center General Hospital
Osaka Red Cross Hospital
5-30, Fudegasaki-cho, Tennoji-ku, Osaka
06-6774-5111
soumudaiichi@osaka-med.jrc.or.jp
NO
2020 | Year | 11 | Month | 07 | Day |
Unpublished
Open public recruiting
2020 | Year | 10 | Month | 30 | Day |
2020 | Year | 11 | Month | 06 | Day |
2020 | Year | 11 | Month | 06 | Day |
2024 | Year | 04 | Month | 30 | Day |
2020 | Year | 11 | Month | 07 | Day |
2022 | Year | 11 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048324
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |